Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-10-23
1989-03-21
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544159, 530331, A61K 3142, C07D26530, C07C 508
Patent
active
048143421
ABSTRACT:
Polypeptides and derivatives thereof containing nor-statine and nor-cyclostatine are useful for inhibiting the angiotensinogen-cleaving action of the enzyme renin.
REFERENCES:
patent: 4645759 (1987-02-01), Luly et al.
patent: 4657931 (1987-04-01), Baran et al.
patent: 4698329 (1987-10-01), Matsueda et al.
patent: 4711958 (1987-12-01), Iizuka et al.
Chemistry Letters, No. 7, 1985, pp. 1041-1044.
Hoover Dennis J.
Rosati Robert L.
Wester Ronald T.
Lumb J. Trevor
McManus James M.
Pfizer Inc.
Phillips Delbert R.
Richardson Peter C.
LandOfFree
Nor-statine and nor-cyclostatine polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nor-statine and nor-cyclostatine polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nor-statine and nor-cyclostatine polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-477224